Women | P value | Total | P value | |
HR (95% CI) | HR (95% CI) | |||
Death | ||||
Low BMImin-1yr (<18.5 kg/m2) | 19.26 (1.73 to >99 999) | 0.013 | 8.50 (1.33 to 98.59) | 0.024 |
Age of onset | 1.06 (0.97 to 175.06) | 0.186 | 1.05 (0.98 to 1.13) | 0.148 |
Short-term use of oral steroid | 1.08 (0.00 to 17.09) | 0.955 | 1.09 (0.07 to 10.94) | 0.942 |
Continuous use of oral steroid | 6.89 (0.40 to >99 999) | 0.165 | 2.50 (0.23 to 19.94) | 0.402 |
Use of immunosuppressant | 0.83 (0.00 to 19.44) | 0.889 | 0.86 (0.08 to 16.27) | 0.908 |
BMImin-1yr, the lowest body mass index measured within 1 year of the first symptoms;NMOSD-AQP4, neuromyelitis optica spectrum disorder with aquaporin-4 immunoglobulin G.